Industry Roundup: Keep Extra-Strength Acetaminophen OTC – McNeil-Backed Survey
This article was originally published in The Tan Sheet
Keep extra-strength acetaminophen OTC – McNeil-backed survey; direct sellers Jenuesse, MonaVie combine; Four Elements makes drug claims; and more news in brief.
You may also be interested in...
Lane Labs in contempt, judge says; NAD delineates between “entire” and “100%”; ERSP eyes stem cell claims; Probiotics lift Schiff brands; more news In Brief.
In a bid to keep 500-mg tablets and 1,000-mg doses of acetaminophen available over the counter, McNeil Consumer Healthcare argues revised dosing instructions would address the root cause of unintentional overdose without unduly restricting access to the popular painkiller
A WHO recommendation to explicitly exempt low-THC CBD from international narcotics controls has been emphatically rejected by UN member states. The CBD industry had hoped for a positive outcome to remove regulatory pressure on product manufacturers in Europe and around the world.